In Conversation

Hong Kong Pharma Report 2018
Latest Reports
Hong Kong Pharma Report 2018
- 2018
Despite its small population size, Hong Kong has long held a strategic interest for the healthcare and life sciences industries, whether as a testbed for innovative products and service delivery models as a result of its efficient regulatory approval system or as an incubator for start-up companies looking to penetrate both mainland Chinese and international markets.   This report features the insights of biotech executives, research scientists, government representatives and the affiliate managers of some of the world’s largest and most innovative pharmaceutical companies who highlight the importance of a national framework for the development of the healthcare and…
Hong Kong Pharma Report
Latest Reports
Hong Kong Pharma Report
- 2017
This report offers companies, investors, policymakers, and stakeholders crucial insight into the rich ecosystem of pharmaceuticals, biotech, and healthcare companies in Hong Kong, based on in-depth interviews conducted with leaders and pioneers across the value chain, from government representatives, country managers of the world’s leading biopharmaceutical companies, representatives from local SMEs and service providers, and the leading figures from Hong Kong’s rich network of research and educational institutes.
We use cookies to ensure that we give you the best experience on our site. For more info click here